Efficacy of Using NLR and IL-6 as Outcome Predictors of HCC - El Gebaly, Ahmed Mohamed
51,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
26 °P sammeln
  • Broschiertes Buch

Hepatocellular carcinoma (HCC) is currently the fifth most common solid tumor worldwide and the third leading cause of cancer-related death. Percutaneous ethanol injection (PEI) and radio frequency ablation (RFA) techniques became well-known procedures for controlling small HCC. Inflammation is a major contributing factor to carcinogenesis specially HCC. Inflammatory mediators including interleukin- 6 (IL-6) and neutrophil to lymphocyte ratio (NLR) are good candidates to stimulate tumor growth and progression.

Andere Kunden interessierten sich auch für
Produktbeschreibung
Hepatocellular carcinoma (HCC) is currently the fifth most common solid tumor worldwide and the third leading cause of cancer-related death. Percutaneous ethanol injection (PEI) and radio frequency ablation (RFA) techniques became well-known procedures for controlling small HCC. Inflammation is a major contributing factor to carcinogenesis specially HCC. Inflammatory mediators including interleukin- 6 (IL-6) and neutrophil to lymphocyte ratio (NLR) are good candidates to stimulate tumor growth and progression.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Current status:-- Lecturer in the Department of Tropical Medicine (Gastroenterology, Hepatology and Infectious Diseases), Faculty of Medicine ¿ Zagazig University,EGYPT. Education:-- M.D.in Tropical Medicine. - M.Sc. in Tropical Medicine.- Bachelor of Medicine and General Surgery(M.B., B.Ch.), excellence with Honor.